We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
109 hedge funds and large institutions have $267M invested in Esperion Therapeutics in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
62% more call options, than puts
Call options by funds: $3.74M | Put options by funds: $2.31M
43% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 28
4% less funds holding
Funds holding: 113 → 109 (-4)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
27% less capital invested
Capital invested by funds: $366M → $267M (-$99M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
109
Holders Change
-4
Holders Change %
-3.54%
% of All Funds
2.91%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
16
Increased
40
Reduced
28
Closed
19
Calls
$3.74M
Puts
$2.31M
Net Calls
+$1.43M
Net Calls Change
+$2.05M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$13.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.3M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$4.98M |
| 4 |
Renaissance Technologies
New York
|
-$4.08M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$2.96M |
